[Clinical experiences with a new topical steroid].

44 patients have been treated in a double-blind trial with Desoximetason (0.25%) and with Betamethasone-valerate (0.1%). It was a randomised left-right comparative trial, and Desoximetason was significantly better than the comparative drug in all observation periods (except the period 1-2 days). Desoximetason has also been tested on 280 patients in an open trial, showing good efficacy and good tolerance.